Investors GSK delivers Q2 2023 Results
Listen to our Q2 2023 results webcast
letsvnp手机版
letsvnp手机版
letsvnp手机版
小米路由ssr
letsvnp手机版
We published our Annual Report 2023 on 04 March 2023. View the summary and download the full report or individual sections.
letsvnp手机版
-
GSK 小米路由ssr
Congratulations to Kimberly Smith, Head of R&D at @ViiVHC, our specialist HIV company, who has received the Scroll of Merit, the @NationalMedAssn's highest award. 小米路由ssr
about 10 hours ago
-
GSK @GSK
Breaking news: we’re in advanced discussions with @EU_Commission, to supply Europe with up to 300m doses of the #COVID19 vaccine candidate we’re co-developing with @sanofi. Learn more: gsk.to/33fp9za
about 3 days ago -
letsvnp手机版
We’re delighted to have been recognised in the #TimesTop50 employer for women in the UK by 小米SSR for our commitment to workplace gender equality and creating an environment where women can progress. Learn more: gsk.to/30YfaLG
about 4 days ago
Find out more
小米SSR
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
Career opportunities at GSK
Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them
Improving health globally
Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach.